Levosimendan therapy in decompensated chronic heart failure: Favourable haemodynamic and neurohormonal effects but for how long?

被引：3
|
作者：
Parissis, JT [1 ]
Farmakis, D [1 ]
Kremastinos, DT [1 ]
机构：
[1] Univ Athens, Sch Med, Dept Cardiol 2, Attikon Univ Hosp, GR-11527 Athens, Greece
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2006年 / 8卷 / 02期
关键词：
D O I：
10.1016/j.ejheart.2006.01.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：215 / 215
页数：1
相关论文
共 50 条
  • [1] Haemodynamic effects of levosimendan in advanced but stable chronic heart failure
    Najjar, Emil
    Stalhberg, Marcus
    Hage, Camilla
    Ottenblad, Erica
    Manouras, Aristomenis
    Lofman, Ida Haugen
    Lund, Lars H.
    ESC HEART FAILURE, 2018, 5 (03): : 302 - 308
  • [2] Levosimendan therapy in decompensated chronic heart failure: Effects on natriuretic peptides and hemodynanic parameters
    Adamopoulos, S
    Parissis, JT
    Farmakis, D
    Kremastinos, DT
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 104 (03) : 357 - 358
  • [3] Therapy of acute decompensated heart failure with levosimendan
    Müller, K
    Peters, A
    Zeus, T
    Hennersdorf, M
    Strauer, BE
    MEDIZINISCHE KLINIK, 2006, 101 : 119 - 122
  • [4] Short-term haemodynamic effects of levosimendan versus prostaglandin E1 in refractory, decompensated chronic heart failure patients
    Berger, R
    Huelsmann, M
    Bojic, A
    Pacher, R
    EUROPEAN HEART JOURNAL, 2002, 23 : 711 - 711
  • [5] Haemodynamic and clinical effects of ularitide in decompensated heart failure
    Mitrovic, Veselin
    Seferovic, Petar M.
    Simeunovic, Dejan
    Ristic, Arsen D.
    Miric, Milutin
    Moiseyev, Valentin S.
    Kobalava, Zhanna
    Nitsche, Klaus
    Forssmann, Wolf-Georg
    Luess, Hartmut
    Meyer, Markus
    EUROPEAN HEART JOURNAL, 2006, 27 (23) : 2823 - 2832
  • [6] Haemodynamic effects of aliskiren in decompensated severe heart failure
    Brancalhao, Euler O.
    Ochiai, Marcelo E.
    Cardoso, Juliano N.
    Vieira, Kelly R.
    Puig, Raphael N.
    Lima, Marcelo V.
    Barretto, Antonio P.
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2012, 13 (01) : 128 - 132
  • [7] Effects of levosimendan on right ventricular function and immune activation in patients with decompensated chronic heart failure
    Bistola, V.
    Parissis, J.
    Kourea, K.
    Farmakis, D.
    Panou, F.
    Filippatos, G.
    Paraskevaidis, I.
    Kremastinos, D.
    EUROPEAN HEART JOURNAL, 2006, 27 : 628 - 628
  • [8] Effects of Levosimendan versus Dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure
    Adamopoulos, Stamatis
    Parissis, John T.
    Iliodromitis, Efstathios K.
    Paraskevaidis, Ioannis
    Tsiapras, Dimitrios
    Farmakis, Dimitrios
    Karatzas, Dimitrios
    Gheorghiade, Mihai
    Filippatos, Gerasimos S.
    Kremastinos, Dimitrios T.
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (01): : 102 - 106
  • [9] Acute therapy with Levosimendan (Simdax®) in decompensated heart failure NYHA IV
    Hardut, D.
    Eisenkoelbl, J.
    Elliott, P.
    Zweng, A.
    Weber, H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2006, 118 (17-18) : A41 - A42
  • [10] Haemodynamic Effects of Anaemia in Patients with Acute Decompensated Heart Failure
    Krzesinski, Pawel
    Galas, Agata
    Gielerak, Grzegorz
    Uzieblo-Zyczkowska, Beata
    CARDIOLOGY RESEARCH AND PRACTICE, 2020, 2020
12345